An2 Therapeutics, Inc. · NASDAQ:ANTX

BML Investment Partners, L.P. reported a 19.20% stake in An2 Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 13, 2025

BML Investment Partners, L.P. reported a 19.20% stake in An2 Therapeutics, Inc., 5,749,432 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).

Stake
19.20%
Shares
5,749,432
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BML Investment Partners, L.P.19.20%5,749,432

Source

View original at SEC

Related